University of Pittsburgh Medical Center, Hillman Cancer Center — Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center, Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pittsburgh Medical Center, Hillman Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: MDS, Desmoid, Desmoid Tumor.

Sponsors: Aprea Therapeutics, Immunome, Inc., Parabilis Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh Medical Center, Hillman Cancer Center?

University of Pittsburgh Medical Center, Hillman Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh Medical Center, Hillman Cancer Center conducted?

University of Pittsburgh Medical Center, Hillman Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers MDS, Desmoid, Desmoid Tumor.

Is University of Pittsburgh Medical Center, Hillman Cancer Center accredited by Crixeo Health?

Yes — University of Pittsburgh Medical Center, Hillman Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Pittsburgh Medical Center, Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.